Back to Search Start Over

Extending kinome coverage by analysis of kinase inhibitor broad profiling data.

Authors :
Jacoby E
Tresadern G
Bembenek S
Wroblowski B
Buyck C
Neefs JM
Rassokhin D
Poncelet A
Hunt J
van Vlijmen H
Source :
Drug discovery today [Drug Discov Today] 2015 Jun; Vol. 20 (6), pp. 652-8. Date of Electronic Publication: 2015 Jan 14.
Publication Year :
2015

Abstract

The explored kinome was extended with broad profiling using the DiscoveRx and Millipore assay panels. The analysis of the profiling of 3368 selected inhibitors on 456 kinases in the DiscoveRx format delivered several insights. First, the coverage depended on the threshold of the selectivity parameter. Second, the relation between hit confirmation rates and inhibitor selectivity showed unexpectedly that higher selectivity can increase the likelihood of false positives. Third, comparing the coverage of a focused to that of a random library showed that the design based on a maximum number of scaffolds was superior to a limited number of scaffolds. Therefore, selective compounds can be used in target validation, enable the jumpstarting of new kinase drug discovery projects, and chart new biological space via phenotypic screening.<br /> (Copyright © 2015 Elsevier Ltd. All rights reserved.)

Details

Language :
English
ISSN :
1878-5832
Volume :
20
Issue :
6
Database :
MEDLINE
Journal :
Drug discovery today
Publication Type :
Academic Journal
Accession number :
25596550
Full Text :
https://doi.org/10.1016/j.drudis.2015.01.002